Drug manufacturer Novartis will pay U.S DoJ $234 million and $113 million to the U.S SEC to settle long time bribery probe. Novartis admitted to paying bribes to doctors to use more of its products in multiple countries across the globe.https://t.co/RIMZDNad6H

— Financial Crime Watch (@FinCrime_Watch) June 25, 2020